Back
Intra-Cellular Therapies Vs. BioNTech SE Industry Stock Comparison
Sell
21
ITCI
Intra-Cellular Therapies
Last Price:
74.65
Seasonality Move:
0.51%
Buy
60
BNTX
BioNTech SE
Last Price:
115.50
Seasonality Move:
12.7%
Sell
21
Intra-Cellular Therapies (ITCI)
is a Sell
Is Intra-Cellular Therapies a Buy, Sell or Hold?
- The current Intra-Cellular Therapies [ITCI] share price is $75.11. The Score for ITCI is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
- ITCI is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
BioNTech SE (BNTX)
is a Buy
Is BioNTech SE a Buy, Sell or Hold?
- The current BioNTech SE [BNTX] share price is $124.71. The Score for BNTX is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- BNTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ITCI Stock Price Chart
What is Intra-Cellular Therapies's stock price today?
-
The Intra-Cellular Therapies share price today is $75.11
The current trend is moderately bullish and ITCI is experiencing selling pressure, which indicates risk of future bearish movement.
BNTX Stock Price Chart
What is BioNTech SE's stock price today?
-
The BioNTech SE share price today is $124.71
The current trend is moderately bullish and BNTX is experiencing slight selling pressure.
ITCI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 53.11 | Buy |
| Chaikin Money Flow: | -208488 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (73.22 - 75.6) | Buy |
| Bollinger Bands (100): | (68.18 - 76.66) | Buy |
BNTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 8.66 | Buy |
| Relative Strength Index (14 RSI): | 87.85 | Buy |
| Chaikin Money Flow: | -1028297 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (82.1 - 106.38) | Buy |
| Bollinger Bands (100): | (81.23 - 98.85) | Buy |
ITCI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 74.65 | Buy |
| 20-day SMA: | 74.17 | Buy |
| 50-day SMA: | 75.78 | Sell |
| 200-day SMA: | 70.36 | Buy |
| 8-day EMA: | 74.7 | Buy |
| 20-day EMA: | 74.51 | Buy |
| 50-day EMA: | 74.31 | Buy |
| 200-day EMA: | 69.75 | Buy |
BNTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 108.39 | Buy |
| 20-day SMA: | 96.29 | Buy |
| 50-day SMA: | 88.86 | Buy |
| 200-day SMA: | 93.01 | Buy |
| 8-day EMA: | 111.31 | Buy |
| 20-day EMA: | 100.3 | Buy |
| 50-day EMA: | 92.84 | Buy |
| 200-day EMA: | 94.5 | Buy |
Intra-Cellular Therapies Earnings Growth & ITCI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.38 per share, an increase next quarter of $0.23 per share, an increase this year of $0.97 per share, and an increase next year of $1.07 per share.
BioNTech SE Earnings Growth & BNTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.71 per share, an increase next quarter of $0.10 per share, a decrease this year of $7.37 per share, and a decrease next year of $0.38 per share.
Intra-Cellular Therapies Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
BioNTech SE Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||